Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Abeona Therapeutics: Q1 Earnings Snapshot AP - Wed May 15, 6:43AM CDT

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.10 (+1.39%)
Abeona Therapeutics: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.10 (+1.39%)
Abeona Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 5.10 (+1.39%)
Abeona Therapeutics: Q1 Earnings Snapshot AP - Thu May 11, 2023

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.10 (+1.39%)
Author
Three Small-Cap Biotech Stocks to Consider Now MarketBeat - Mon Dec 12, 2022

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 23.01 (+0.09%)
HTGM : 0.4800 (-20.00%)
ABEO : 5.10 (+1.39%)
Abeona Therapeutics: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.10 (+1.39%)
Abeona Therapeutics Reports Second Quarter 2022 Financial Results Globe Newswire - Thu Aug 11, 2022

Disposition of MPS programs allows Abeona to extend runway of current cash into 2Q 2023 Phase 3 VIITAL™ study topline data expected in late-3Q/early-4Q...

ABEO : 5.10 (+1.39%)
Abeona Therapeutics Regains Compliance with Nasdaq Listing Requirements Globe Newswire - Wed Jul 20, 2022

NEW YORK and CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it received notice from The Nasdaq...

ABEO : 5.10 (+1.39%)
Abeona Therapeutics to Present at the Jefferies Healthcare Conference Globe Newswire - Mon Jun 6, 2022

NEW YORK and CLEVELAND, June 06, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy,...

ABEO : 5.10 (+1.39%)
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule Globe Newswire - Thu May 19, 2022

NEW YORK and CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy,...

ABEO : 5.10 (+1.39%)

Barchart Exclusives

3 High Dividend Stocks Beginning To Breakout Off Their 52-Week Lows Barchart - Fri Jul 26, 6:00PM CDT
These stocks have recently hit their 52-week lows and are highly rated. Is now the time to buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot